Particulars (Rupees in Crores.) | Mar-2025 | Sept-2024 | Mar-2024 | Sept-2023 | Mar-2023 |
---|---|---|---|---|---|
Gross Sales | 1,025.19 | 792.51 | 828.65 | 509.82 | 684.63 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 1,025.19 | 792.51 | 828.65 | 509.82 | 684.63 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | -0.57 | 15.05 | 5.77 | 0.71 | 44.04 |
Total Income | 1,024.62 | 807.56 | 834.42 | 510.53 | 728.67 |
Total Expenditure | 734.98 | 600.93 | 602.11 | 435.42 | 598.09 |
PBIDT | 289.63 | 206.64 | 232.31 | 75.11 | 130.58 |
Interest | 22.05 | 20.04 | 40.54 | 49.19 | 54.13 |
PBDT | 267.59 | 186.6 | 191.78 | 25.92 | 76.45 |
Depreciation | 18.82 | 17.63 | 17.15 | 15.6 | 19.1 |
Minority Interest Before NP | 0 | 0 | 0 | 0 | 0 |
Tax | 64.58 | 38.93 | 39.4 | 7 | 13.79 |
Deferred Tax | -5.02 | 3.24 | -12.28 | -0.03 | -0.84 |
Reported Profit After Tax | 189.21 | 126.8 | 147.51 | 3.35 | 44.4 |
Minority Interest After NP | 0 | 0 | 0 | 0 | 0 |
Net Profit after Minority Interest | 189.21 | 126.8 | 147.51 | 3.35 | 44.4 |
Extra-ordinary Items | -9.07 | 0 | 0 | 0 | 30.45 |
Adjusted Profit After Extra-ordinary item | 198.28 | 126.8 | 147.51 | 3.35 | 13.95 |
EPS (Unit Curr.) | 8.32 | 5.57 | 6.49 | 0.19 | 2.7 |
Book Value (Unit Curr.) | 0 | 0 | 0 | 0 | 0 |
Dividend (%) | 0 | 0 | 0 | 0 | 0 |
Equity | 45.48 | 45.49 | 45.48 | 39.15 | 32.93 |
Public Shareholding (Number) | 0 | 0 | 0 | 0 | 0 |
Public Shareholding (%) | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - No. of Shares | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - % in Total Promoters Holding | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - % in Total Equity | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - No. of Shares | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - % in Total Promoters Holding | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - % in Total Equity | 0 | 0 | 0 | 0 | 0 |
PBIDTM(%) | 28.25 | 26.07 | 28.03 | 14.73 | 19.07 |
PBDTM(%) | - | - | - | - | - |
PATM(%) | 18.45 | 15.99 | 17.8 | 0.65 | 6.48 |
At the end of the June quarter, Paresh owned 1.12% of Sun Pharma Advanced Research, while his brother Vijay owned 1.13% of the company.
Here are some of the stocks that may see significant price movement today: HPCL, PNB Housing, Colgate-Palmolive, etc.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.